New combo vaccine trial targets RSV and bird flu

NCT ID NCT07516418

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Apr 09, 2026 · Last updated May 09, 2026 · Updated 5 times

Summary

This early-stage study tests the safety and immune response of experimental vaccines for respiratory syncytial virus (RSV) and a type of bird flu (H5N1) in 570 healthy adults aged 18 to 49. Participants will receive different vaccine formulas and be monitored for side effects and antibody levels over about 6 to 7 months. The goal is to find safe and promising vaccine designs for further development.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site # 036006

    RECRUITING

    Taringa, Queensland, 4068, Australia

  • Site # 03610004

    RECRUITING

    South Brisbane, Queensland, 4104, Australia

  • Site # 0361001

    RECRUITING

    Herston, Queensland, 4006, Australia

  • Site # 0361002

    RECRUITING

    Griffith, Queensland, 4222, Australia

  • Site # 0361003

    RECRUITING

    Morayfield, Queensland, 4506, Australia

  • Site # 0361005

    RECRUITING

    Sippy Downs, Queensland, 4556, Australia

Conditions

Explore the condition pages connected to this study.